GlassScriptPhysician profile
Russell E Davenport
NPI 1881012441
$25,642.95
in general payments reported to CMS, 2019-2025
21 companies · $2,578 in 2025
The $2,578 reported for 2025 was more than what 86% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,583 · 2020: $1,476 · 2021: $1,507 · 2022: $5,260 · 2023: $6,811 · 2024: $2,428 · 2025: $2,578.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,882 · Education: $1,006 · Travel and Lodging: $929.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,882.10 |
| Education | $1,005.81 |
| Travel and Lodging | $929.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $7,949.13 | 2019-2024 | Senza |
| Boston Scientific Corporation | $6,487.82 | 2019-2025 | Wavewriter Alpha Prime 16, Intracept |
| Abbott Laboratories | $4,413.48 | 2019-2025 | Proclaim, Eterna |
| Medtronic, INC. | $2,108.20 | 2022-2025 | Inceptiv, Intellis Adaptivestim, Accurian |
| Medtronic USA, INC. | $1,250.45 | 2019 | |
| Globus Medical, INC. | $947.25 | 2025 | Senza |
| Saluda Medical Americas, INC. | $589.31 | 2023-2025 | Evoke Scs, Evoke |
| Spr Therapeutics, INC | $489.64 | 2019-2025 | Sprint Pns System |
| Abbvie INC. | $218.06 | 2023-2025 | Botox |
| Nalu Medical, INC. | $216.91 | 2021-2023 | Nalu Neurostimulation System |
| Avanos Medical | $189.61 | 2019 | |
| Spinal Simplicity, LLC | $135.83 | 2025 | Ha Minuteman G3-R |
| Vertex Pharmaceuticals Incorporated | $124.02 | 2025 | |
| Vertos Medical, INC. | $117.83 | 2020 | |
| Livanova USA, INC. | $109.41 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tersera Therapeutics LLC | $100.83 | 2019 | |
| Painteq LLC | $76.91 | 2022 | |
| Stryker Corporation | $74.83 | 2019 | |
| Curonix LLC | $16.86 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Convatec INC. | $14.06 | 2024 | |
| Bioventus LLC | $12.51 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Russell Davenport listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.